Multivariate Cox regression analysis suggested that AHNAK2 could become an independent predictor after adjusting for other parameters, including age, gender, American Joint Committee on Cancer (AJCC) stage, BRAF mutations, RAS mutations and tumor mutation burden (TMB) (Table 1) (PFS as the ending indicator). This evidence concerns the gene BRAF and neoplasm.